Drug Shortage Report for MYLAN-MONTELUKAST

Last updated on 2017-09-08 History
Report ID 7052
Drug Identification Number 02380749
Brand name MYLAN-MONTELUKAST
Common or Proper name MONTELUKAST
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) MONTELUKAST
Strength(s) 4MG
Dosage form(s) TABLET (CHEWABLE)
Route of administration ORAL
Packaging size 30BL
ATC code R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-04-11
Estimated end date
Actual end date 2017-09-07
Shortage status Resolved
Updated date 2017-09-08
Company comments Discontinuation reported under ID 16138.
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2017-09-08 French Compare
v3 2017-09-08 English Compare
v2 2017-04-13 French Compare
v1 2017-04-13 English Compare

Showing 1 to 4 of 4